hCALCRL mutation causes autosomal recessive nonimmune hydrops fetalis with lymphatic dysplasia
暂无分享,去创建一个
M. Caron | J. Berg | H. Kliman | J. Simms | D. Poyner | K. Caron | Natalie R. Nielsen | J. Snyder | F. Al Mutairi | Reema B. Davis | Daniel O. Kechele | D. Mackie
[1] J. Simms,et al. Data underpinning article "Molecular dynamic simulations of CLR/RAMP1 and CLR/RAMP2 heterodimers, with and without deletions of V205 in CLR" , 2018 .
[2] S. Silberstein,et al. Fremanezumab for the Preventive Treatment of Chronic Migraine , 2017, The New England journal of medicine.
[3] P. Goadsby,et al. A Controlled Trial of Erenumab for Episodic Migraine , 2017, The New England journal of medicine.
[4] R. Helaers,et al. Loss of ADAMTS3 activity causes Hennekam lymphangiectasia–lymphedema syndrome 3 , 2017, Human molecular genetics.
[5] J. Simms,et al. Relative Antagonism of Mutants of the CGRP Receptor Extracellular Loop 2 Domain (ECL2) Using a Truncated Competitive Antagonist (CGRP8-37): Evidence for the Dual Involvement of ECL2 in the Two-Domain Binding Model. , 2017, Biochemistry.
[6] Chris de Graaf,et al. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators , 2017, Nature.
[7] Hualiang Jiang,et al. Structure of the full-length glucagon class B G protein-coupled receptor , 2017, Nature.
[8] K. Caron,et al. Lymphatic deletion of calcitonin receptor-like receptor exacerbates intestinal inflammation. , 2017, JCI insight.
[9] M. Caron,et al. Inhibiting clathrin-mediated endocytosis of the leucine-rich G protein-coupled receptor-5 diminishes cell fitness , 2017, The Journal of Biological Chemistry.
[10] K. Caron,et al. Endothelial Restoration of Receptor Activity–Modifying Protein 2 Is Sufficient to Rescue Lethality, but Survivors Develop Dilated Cardiomyopathy , 2016, Hypertension.
[11] A. Hoischen,et al. EPHB4 kinase–inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis , 2016, The Journal of clinical investigation.
[12] Christopher A. Reynolds,et al. Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties , 2016, The Journal of Biological Chemistry.
[13] B. Hille,et al. Complete Reversible Refolding of a G-Protein Coupled Receptor on a Solid Support , 2016, PloS one.
[14] M. Caron,et al. A rapid and affordable screening platform for membrane protein trafficking , 2015, BMC Biology.
[15] U. Yallampalli,et al. Involvement of Receptor Activity-Modifying Protein 3 (RAMP3) in the Vascular Actions of Adrenomedullin in Rat Mesenteric Artery Smooth Muscle Cells1 , 2015, Biology of reproduction.
[16] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[17] A. Patapoutian,et al. Impaired PIEZO1 function in patients with a novel autosomal recessive congenital lymphatic dysplasia , 2015, Nature Communications.
[18] Shin Lin,et al. Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis , 2015, Nature Communications.
[19] G. Ladds,et al. Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2)* , 2015, The Journal of Biological Chemistry.
[20] R. Hennekam,et al. Etiology of non‐immune hydrops fetalis: An update , 2015, American journal of medical genetics. Part A.
[21] Rodrigo Lopez,et al. The EMBL-EBI bioinformatics web and programmatic tools framework , 2015, Nucleic Acids Res..
[22] R. Hennekam,et al. Hennekam syndrome can be caused by FAT4 mutations and be allelic to Van Maldergem syndrome , 2014, Human Genetics.
[23] A. Waggoner,et al. Self-Checking Cell-Based Assays for GPCR Desensitization and Resensitization , 2014, Journal of biomolecular screening.
[24] Marco Biasini,et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information , 2014, Nucleic Acids Res..
[25] S. Mansour,et al. The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings , 2013, Clinical genetics.
[26] K. Caron,et al. G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection. , 2013, Journal of molecular endocrinology.
[27] A. Conner,et al. Comparing the molecular pharmacology of CGRP and adrenomedullin. , 2013, Current protein & peptide science.
[28] Ali Jazayeri,et al. Structure of class B GPCR corticotropin-releasing factor receptor 1 , 2013, Nature.
[29] M. Kadmiel,et al. Fetal-derived adrenomedullin mediates the innate immune milieu of the placenta. , 2013, The Journal of clinical investigation.
[30] Rodrigo Lopez,et al. Analysis Tool Web Services from the EMBL-EBI , 2013, Nucleic Acids Res..
[31] N. Mochizuki,et al. Vascular Endothelial Adrenomedullin-RAMP2 System Is Essential for Vascular Integrity and Organ Homeostasis , 2013, Circulation.
[32] S. Mansour,et al. FLT4/VEGFR3 and Milroy Disease: Novel Mutations, a Review of Published Variants and Database Update , 2013, Human mutation.
[33] R. Gainetdinov,et al. BRET biosensors to study GPCR biology, pharmacology, and signal transduction , 2012, Front. Endocrin..
[34] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[35] M. Wheatley,et al. The role of the extracellular loops of the CGRP receptor, a family B GPCR. , 2012, Biochemical Society transactions.
[36] R. Hennekam,et al. Non‐immune hydrops fetalis: A short review of etiology and pathophysiology , 2012, American journal of medical genetics. Part A.
[37] R. Adams,et al. Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation. , 2012, Developmental cell.
[38] D. Higgins,et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.
[39] D. Poyner,et al. Extracellular loops 1 and 3 and their associated transmembrane regions of the calcitonin receptor-like receptor are needed for CGRP receptor function , 2011, Biochimica et biophysica acta.
[40] Y. Takei,et al. Shared and separate functions of the RAMP-based adrenomedullin receptors , 2011, Peptides.
[41] Y. Mukouyama,et al. Whole-mount immunohistochemical analysis for embryonic limb skin vasculature: a model system to study vascular branching morphogenesis in embryo. , 2011, Journal of visualized experiments : JoVE.
[42] M. Kadmiel,et al. Research resource: Haploinsufficiency of receptor activity-modifying protein-2 (RAMP2) causes reduced fertility, hyperprolactinemia, skeletal abnormalities, and endocrine dysfunction in mice. , 2011, Molecular endocrinology.
[43] Marco Biasini,et al. Toward the estimation of the absolute quality of individual protein structure models , 2010, Bioinform..
[44] A. Randenberg. Nonimmune Hydrops Fetalis Part II: Does Etiology Influence Mortality? , 2010, Neonatal Network.
[45] A. Randenberg. Nonimmune Hydrops Fetalis Part I: Etiology and Pathophysiology , 2010, Neonatal Network.
[46] S. Mansour,et al. Linkage and sequence analysis indicate that CCBE1 is mutated in recessively inherited generalised lymphatic dysplasia , 2010, Human Genetics.
[47] Ying Xu,et al. Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning , 2009, The Journal of experimental medicine.
[48] Torsten Schwede,et al. Automated comparative protein structure modeling with SWISS‐MODEL and Swiss‐PdbViewer: A historical perspective , 2009, Electrophoresis.
[49] R. Hennekam,et al. Etiology of nonimmune hydrops fetalis: A systematic review , 2009, American journal of medical genetics. Part A.
[50] Carolina Wählby,et al. BlobFinder, a tool for fluorescence microscopy image cytometry , 2009, Comput. Methods Programs Biomed..
[51] K. Caron,et al. Haploinsufficiency for Adrenomedullin Reduces Pinopodes and Diminishes Uterine Receptivity in Mice1 , 2008, Biology of reproduction.
[52] F. Orsenigo,et al. Sox18 induces development of the lymphatic vasculature in mice , 2008, Nature.
[53] Torsten Schwede,et al. The SWISS-MODEL Repository and associated resources , 2008, Nucleic Acids Res..
[54] T. Sotnikova,et al. Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP Biosensor , 2008, Molecular Pharmacology.
[55] James A J Fitzpatrick,et al. Fluorogen-activating single-chain antibodies for imaging cell surface proteins , 2008, Nature Biotechnology.
[56] K. Caron,et al. Adrenomedullin signaling is necessary for murine lymphatic vascular development. , 2008, The Journal of clinical investigation.
[57] T. Koyama,et al. The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity. , 2008, The Journal of clinical investigation.
[58] D. Baker,et al. Toward high-resolution prediction and design of transmembrane helical protein structures , 2007, Proceedings of the National Academy of Sciences.
[59] M. Tsai,et al. Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. , 2007, Genes & development.
[60] O. Smithies,et al. Receptor Activity-modifying Proteins 2 and 3 Have Distinct Physiological Functions from Embryogenesis to Old Age* , 2007, Journal of Biological Chemistry.
[61] T. Magnuson,et al. Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice. , 2006, The Journal of clinical investigation.
[62] R. Hennekam,et al. Nonimmune idiopathic hydrops fetalis and congenital lymphatic dysplasia , 2006, American journal of medical genetics. Part A.
[63] O. Smithies,et al. Hydrops Fetalis, Cardiovascular Defects, and Embryonic Lethality in Mice Lacking the Calcitonin Receptor-Like Receptor Gene , 2006, Molecular and Cellular Biology.
[64] Torsten Schwede,et al. BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .
[65] J. Henley,et al. Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane , 2005, Journal of Cell Science.
[66] D. Smith,et al. CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22–52, CGRP8–37 and BIBN4096BS , 2003, British journal of pharmacology.
[67] R. Kingston,et al. Calcium Phosphate Transfection , 2003, Current protocols in cell biology.
[68] P. Sexton,et al. Novel Receptor Partners and Function of Receptor Activity-modifying Proteins* , 2003, The Journal of Biological Chemistry.
[69] P. Sexton,et al. Receptor activity modifying proteins. , 2001, Cellular signalling.
[70] O. Smithies,et al. Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional Adrenomedullin gene. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[71] M. W. Glynn,et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. , 2000, American journal of human genetics.
[72] S. Angers,et al. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. , 2000, The Journal of clinical investigation.
[73] S. Foord,et al. Pharmacological characterization of receptor-activity-modifying proteins (RAMPs) and the human calcitonin receptor. , 1999, Journal of pharmacological and toxicological methods.
[74] M. Asakawa,et al. The RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells , 1999, FEBS letters.
[75] Melanie G. Lee,et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.
[76] A. Verkman,et al. Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. , 1998, The Journal of clinical investigation.
[77] K. Alitalo,et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[78] K. Alitalo,et al. A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3) and KDR (VEGFR‐2) receptor tyrosine kinases. , 1996, The EMBO journal.
[79] M. Apkon,et al. Pathophysiology of hydrops fetalis. , 1995, Seminars in perinatology.
[80] T. Blundell,et al. Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.
[81] F. Collins,et al. Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. , 1991, Science.
[82] R. Brace. Effects of outflow pressure on fetal lymph flow. , 1989, American journal of obstetrics and gynecology.
[83] R. Hennekam,et al. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans , 2009, Nature Genetics.
[84] Silvio C. E. Tosatto,et al. Global and local model quality estimation at CASP8 using the scoring functions QMEAN and QMEANclust , 2009, Proteins.
[85] Wolfgang Rieping,et al. Bmc Structural Biology Relationship between Chemical Shift Value and Accessible Surface Area for All Amino Acid Atoms , 2009 .
[86] P. Sexton,et al. GPCR modulation by RAMPs. , 2006, Pharmacology & therapeutics.
[87] R. Bukowski,et al. Hydrops fetalis. , 2000, Clinics of Perinatology.
[88] E. Kattner,et al. Hydrops fetalis: manifestation in lysosomal storage diseases including Farber disease , 1997, European Journal of Pediatrics.
[89] K. Alitalo,et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. , 1996, The EMBO journal.
[90] G. Valenzuela,et al. Effects of outflow pressure and vascular volume loading on thoracic duct lymph flow in adult sheep. , 1990, The American journal of physiology.